儿童耐药性 产后发作:临床概况和预测因素
Warisara Saenchai1, Satit Manopunya2, Shanika Kosarat2
1Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
新生儿发作,通常是由围产期窒息引起的,可以导致. 严重的发育障碍和特定的类型是儿童耐药性的关键预测因素.
科学领域:
- 新生儿神经学 新生儿神经学
- 儿科是儿童的.
- 临床结果研究研究的临床结果.
背景情况:
- 新生儿发作是儿科的一个关键问题,对长期的神经发育有重大影响.
- 了解新生儿发作的病因和结果对于有效的治疗和干预至关重要.
研究的目的:
- 研究新生儿发作的临床特征,原因和结果.
- 在经历新生儿的儿童中确定耐药性 (DRE) 的预测因子.
主要方法:
- 从2008年到2023年,在清迈大学医院对218名患有发作的新生儿进行了回顾性图表审查.
- 新生儿发作的诊断通过临床发现和/或脑电图得到证实.
- 耐药性 (DRE) 被定义为未能通过两种抗发作药物控制.
主要成果:
- 围产期窒息是新生儿发作的主要原因 (58.7%),其次是出血 (7.8%).
- 在27.3%的患者中发生发作,其中48.7%的患者符合DRE标准.
- DRE的独立风险因素包括严重的发育障碍和发作或多次发作的发生.
结论:
- 围产期窒息是新生儿发作的主要病因.
- 患有发作的新生儿中有很大一部分患有,其中一半的病例是耐药的.
- 深度发育障碍,发作和多次发作类型是识别新生儿DRE高风险的关键预测因素.
更多相关视频
09:29Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice
Published on: June 11, 2020
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
相关概念视频
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
